These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16568459)

  • 1. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
    Belknap SM; Kuzel TM; Yarnold PR; Slimack N; Lyons EA; Raisch DW; Bennett CL
    Cancer; 2006 May; 106(9):2051-7. PubMed ID: 16568459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An autopsy case of acute pulmonary toxicity associated with gemcitabine.
    Maniwa K; Tanaka E; Inoue T; Kato T; Sakuramoto M; Minakuchi M; Maeda Y; Noma S; Kobashi Y; Taguchi Y
    Intern Med; 2003 Oct; 42(10):1022-5. PubMed ID: 14606719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Favorable outcome of gemcitabine-induced acute respiratory distress syndrome].
    Bonnichon A; Vedrine L; Aletti M; Le Moulec S; Borne M; Margery J; Bauduceau O; Fayolle M; Ceccaldi B
    Rev Pneumol Clin; 2007 Dec; 63(6):379-83. PubMed ID: 18166944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.
    Min R; Li T; Du J; Zhang Y; Guo J; Lu WL
    Can J Physiol Pharmacol; 2008 May; 86(5):288-98. PubMed ID: 18432290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden cardio-pulmonary toxicity following a single infusion of gemcitabine.
    Ciotti R; Belotti G; Facchi E; Cantù A; D'Amico A; Gatti C
    Ann Oncol; 1999 Aug; 10(8):997. PubMed ID: 10509166
    [No Abstract]   [Full Text] [Related]  

  • 8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute lung injury induced by gemcitabine.
    Linskens RK; Golding RP; van Groeningen CJ; Giaccone G
    Neth J Med; 2000 Jun; 56(6):232-5. PubMed ID: 10821980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcome of gemcitabine-induced respiratory distress syndrome.
    Girard T; Mouthon L; Boaziz C; Andre MH; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):306-8. PubMed ID: 10922960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine-related pulmonary toxicity.
    Joerger M; Gunz A; Speich R; Pestalozzi BC
    Swiss Med Wkly; 2002 Jan; 132(1-2):17-20. PubMed ID: 11901447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute respiratory distress syndrome after antineoplastic chemotherapy. Probable role of gemcitabine].
    de Lavigerie B; Joasson JM
    Presse Med; 2001 May 5-12; 30(17):851-4. PubMed ID: 11402938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma.
    Dunsford ML; Mead GM; Bateman AC; Cook T; Tung K
    Ann Oncol; 1999 Aug; 10(8):943-7. PubMed ID: 10509156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):19-24. PubMed ID: 12712259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
    Lopez M
    Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine-induced respiratory failure associated with elevated erythrocyte sedimentation rate (ESR).
    Davidoff S; Shah RD; Arunabh T
    Respir Med; 2006 Apr; 100(4):760-3. PubMed ID: 16199150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.
    Binder D; Hübner RH; Temmesfeld-Wollbrück B; Schlattmann P
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1575-83. PubMed ID: 21547571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.